|
Volumn 28, Issue 5, 2009, Pages 180-182
|
Role of intravenous naloxone in severe pruritus of acute cholestasis
|
Author keywords
Cholestasis; Naloxone; Open label study
|
Indexed keywords
ALKALINE PHOSPHATASE;
BILIRUBIN;
GAMMA GLUTAMYLTRANSFERASE;
NALOXONE;
ABSENCE OF SIDE EFFECTS;
ADULT;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ARTICLE;
BILIRUBIN BLOOD LEVEL;
BOLUS INJECTION;
BREAKTHROUGH PHENOMENON;
CHOLESTASIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CYTOMEGALOVIRUS INFECTION;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
FEMALE;
GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL;
HEPATITIS A;
HEPATITIS B;
HEPATITIS E;
HERPES SIMPLEX;
HUMAN;
MALE;
PROSPECTIVE STUDY;
PRURITUS;
SHORT COURSE THERAPY;
SYMPTOM;
VIRUS HEPATITIS;
VISUAL ANALOG SCALE;
ACUTE DISEASE;
INTRAVENOUS DRUG ADMINISTRATION;
ACUTE DISEASE;
ADULT;
CHOLESTASIS;
FEMALE;
HUMANS;
INJECTIONS, INTRAVENOUS;
MALE;
NALOXONE;
PROSPECTIVE STUDIES;
PRURITUS;
|
EID: 77951882324
PISSN: 02548860
EISSN: 02548860
Source Type: Journal
DOI: 10.1007/s12664-009-0070-8 Document Type: Article |
Times cited : (11)
|
References (9)
|